Cosmo Pharmaceuticals NV (CMOPF)

152.00 -6.04 (-3.82%) USD  |  OTCM  |  Feb 23, 12:47
More

Cosmo Pharmaceuticals Ending Cash (Quarterly)

Ending Cash (Quarterly) Chart

View Ending Cash (Quarterly) for CMOPF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Ending Cash (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Ending Cash (Quarterly) Range, Past 5 Years

View Ending Cash (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Ending Cash (Quarterly) Benchmarks

View Ending Cash (Quarterly) Benchmarks
Start Trial
Amarin Corp. Plc Upgrade
Jazz Pharmaceuticals Plc Upgrade
Prothena Corp. Plc --
Iterum Therapeutics Plc Upgrade
GH Research Plc Upgrade